Ofloxacin (CAS 82419-36-1)

Ofloxacin is a fluoroquinolone antibiotic widely studied for its potent antibacterial activity and distinct mechanism of action. It functions by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication, transcription, repair, and recombination. By stabilizing the DNA-enzyme complexes and preventing the relegation of the cleaved DNA strands, ofloxacin induces double-strand breaks, leading to the disruption of DNA synthesis and cell death. This mode of action is particularly effective against a broad range of Gram-negative and Gram-positive bacteria. In scientific research, ofloxacin is extensively utilized to investigate the mechanisms of bacterial resistance, focusing on mutations in the target enzymes that reduce drug binding and the role of efflux pumps that expel the antibiotic from bacterial cells. Researchers employ ofloxacin to study the structure-activity relationships of fluoroquinolones, aiming to develop new derivatives with improved efficacy and reduced resistance potential. It serves as a model compound in pharmacokinetic and pharmacodynamic studies to understand the drug′s behavior in biological systems, including absorption, distribution, metabolism, and excretion. Ofloxacin is also used in molecular biology to investigate the regulation of DNA repair pathways and the cellular responses to DNA damage. Its ability to induce specific DNA lesions makes it a valuable tool for studying genotoxic stress and the mechanisms involved in maintaining genomic integrity.